Developing a potent antiviral drug for use in stem cell transplants.
Industry: Health Care
First Day Return: +34.2%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 03/08/2013 |
Offer Price | $14.00 |
Price Range $13.00 - $15.00 | |
Offer Shares (mm) | 7.3 |
Deal Size ($mm) | $102 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 04/10/2013 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $102 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Durham, NC, United States |
Founded | 2000 |
Employees at IPO | 46 |
Website www.chimerix.com |